Transglutaminase inhibitors

Chemistry: natural resins or derivatives; peptides or proteins; – Peptides of 3 to 100 amino acid residues – Tripeptides – e.g. – tripeptide thyroliberin – etc.

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C07K 500

Patent

active

049702971

ABSTRACT:
This invention is directed to compounds of the formula: ##STR1## or an optical isomer thereof, or a pharmaceutically acceptable salt thereof, wherein:
n is 0, 1 or 2;
p and q are independently 0, 1 or 2 and the sum of (p+q) is less than or equal to 3;
X is selected from the group consisting of: halo; --OR.sup.2, --SR.sup.2, --S(O)R.sup.2, --S(O).sub.2 R.sup.2, and --S(O).sub.2 NHR.sup.2, wherein R.sup.2 is lower alkyl, mono-, di- or tri-fluoro alkyl of 2 or 3 carbon atoms, optionally substituted aryl;
R is H or an N-protecting group;
R.sup.1 is alkylthio, arylthio, amino, alkylamino, optionally substituted arylamino, or optionally substituted aralkylamino; and when the sum of n+p+q is greater than or equal to one, R.sup.1 is also hydroxy, alkoxy, or aralkoxy; and
each (aa) is independently an .alpha.-amino acid residue with an optionally protected amino acid side chain.

REFERENCES:
patent: 4128542 (1978-12-01), Atherton et al.
patent: 4276288 (1981-06-01), Etschenberg et al.
patent: 4305852 (1981-12-01), Garsky
patent: 4397853 (1983-08-01), Kawakita et al.
patent: 4593024 (1986-06-01), Lu et al.
patent: 4657899 (1987-04-01), Rzeszotarski et al.
patent: 4694016 (1987-09-01), Lu et al.
J. Med. Chem. (1985), 28(5),668-672, Lauridsen et al.
Cancer Chemotherapy Reports, vol. 58, 6 (1974), Cooney et al.
Chem. Abs., vol. 102, 1985, 20 3802 k.
Chem. Abs., vol. 94, 1981, 16038v.
Chem. Abs., vol. 82, 1975, 149188t.
Organic Chemistry, vol. 6, 2nd, pp. 140-141.
Organic Chemistry, 3rd ed., Chap. 36, p. 1152.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Transglutaminase inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Transglutaminase inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Transglutaminase inhibitors will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-777764

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.